• New FDA Pulse Oximetry Guidance: Strengths and Weaknesses

  • Mar 5 2025
  • Duración: 17 m
  • Podcast

New FDA Pulse Oximetry Guidance: Strengths and Weaknesses

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • The US Food and Drug Administration (FDA) issued new draft regulatory guidance for pulse oximeters related to skin pigment. The guidance is a step forward but it may have unintended consequences. Authors Michael Lipnick, MD, and Philip Bicker, MD, PhD, professors of anesthesia at University of California, San Francisco, discuss this and more with JAMA Executive Editor Gregory Curfman, MD.

    Related Content:

    • Pulse Oximetry and Skin Pigmentation—New Guidance From the FDA
    • Adherence to FDA Guidance on Pulse Oximetry Testing Among Diverse Individuals, 1996-2024
    • Addressing Racial and Ethnic Bias in Pulse Oximeters—A Wicked Problem
    • Evaluating the Accuracy of Pulse Oximetry in Children According to Race
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre New FDA Pulse Oximetry Guidance: Strengths and Weaknesses

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles